The global demand for Multiplex Assays Market is presumed to reach the market size of nearly USD 13.19 Billion by 2032 from USD 3.53 Billion in 2023 with a CAGR of 15.77% under the study period 2024 - 2032.
The multiplex assay is a term used in biological sciences, which referred to the type of immunoassay that uses magnetic beads to simultaneously measure multiple analyte in a single experiment. Basically, a multiplex assay is a derivative of an ELISA (enzyme-linked immunosorbent assay) using beads for binding the capture antibody. Multiple assays offer several distinct advantages over single-plex assays. The most obvious is that it enables researchers to extract more data from a given amount of sample at the same time as a single-plex assay.
Market Dynamics
The increasing usage of multiplex assays in companion diagnostics is primarily driving the market growth. The advantages of multiplex assays over singleplex and traditional assays are again supporting the market presence. However, high equipment cost and stringent regulations and standards are likely to hamper market growth. Whereas, rising need for high-throughput and automated systems are expected to create potential opportunity over the forecast period.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of multiplex assays.
Market Segmentation
The entire multiplex assays market has been sub-categorized into product, assay type, and technology. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product
- Consumables
- Instruments
- Software
By Type
- Protein Multiplex Assays (Planar Protein Assays, Bead-based Protein Assays)
- Nucleic Acid Multiplex Assays (Planar Protein Assays, Bead-based Protein Assays)
- Cell-based Multiplex Assays
By Technology
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex Real-time PCR
- Other Technologie
By Application
- Research & Development (Drug Discovery & Development, Biomarker Discovery & Validation)
- Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Metabolism & Endocrinology Disorders, Other Diseases)
By End-user
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic laboratories
- Research & Academic Institutes
- Other End-users
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for multiplex assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Multiplex Assays Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the multiplex assays market include Bio-Rad Laboratories, Inc. Thermo Fisher Scientific, Seegene Inc., Luminex Corporation, Abcam plc., Promega Connections, QIAGEN N.V., Perkin Elmer Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.